Quantum Blue® Adalimumab

The biologic drug Adalimumab is a therapeutic monoclonal antibody. It acts as an antagonist to TNF alpha, thus effectively blocks the inflammatory process in numerous chronic inflammatory diseases like Crohn’s disease, ulcerative colitis and inflammatory arthritis. The BÜHLMANN  Quantum Blue® Adalimumab is the first rapid test to measure adalimumab trough levels in patient’s serum to allow immediate decision making for potential drug dose adjustments.

Quantum Blue® Infliximab

The biologic drug Infliximab is a therapeutic monoclonal antibody. It acts as an antagonist to TNF alpha, thus effectively blocks the inflammatory process in numerous chronic inflammatory diseases like Crohn’s disease, ulcerative colitis and inflammatory arthritis. The BÜHLMANN  Quantum Blue® Infliximab is the first rapid test to measure infliximab trough levels in patient’s serum to allow immediate decision making for potential drug dose adjustments.